Intraductal Papillary Mucinous Neoplasm (IPMN)

Intraductal Papillary Mucinous Neoplasm, or IPMN, is a type of cyst that grows in the pancreas. These cysts form in the ducts, or tubes, that carry digestive enzymes from your pancreas to your intestine. The cysts produce mucin, a thick gel-like substance that can block the ducts and cause inflammation.

IPMNs matter because some of them can turn into pancreatic cancer over time. Not all IPMNs become cancerous, but doctors watch them closely to catch any changes early. The cysts can be small and stay stable for years, or they can grow and develop worrisome features that need treatment.

There are different types of IPMNs based on where they grow in the pancreas. Main duct IPMNs affect the large central duct and carry higher cancer risk. Branch duct IPMNs grow in smaller side ducts and usually have lower risk. Knowing which type you have helps your doctor decide on the right monitoring or treatment plan.

• Recurring belly pain, especially in the upper abdomen
• Back pain that comes and goes
• Nausea and vomiting during pain episodes
• Yellowing of the skin or eyes, called jaundice
• Unexpected weight loss
• New onset diabetes in adults over 50
• Greasy stools that float
• Loss of appetite

Many people with IPMN have no symptoms at all. The cysts are often found by accident during imaging tests for other reasons. When symptoms do appear, they usually mean the cyst has grown large enough to block pancreatic ducts or has caused inflammation.

Doctors are still learning what causes IPMNs to form. These cysts develop when cells lining the pancreatic ducts begin to grow abnormally and produce excess mucin. Age is a major risk factor, with most IPMNs found in people over 60. Smoking appears to increase the risk of developing IPMNs and may speed up their progression to cancer. Some genetic conditions that run in families can raise the risk of pancreatic cysts and cancer.

Chronic inflammation of the pancreas may play a role in IPMN development. People with a family history of pancreatic cancer have higher risk. Certain inherited syndromes, like Peutz-Jeghers syndrome and familial adenomatous polyposis, are linked to increased IPMN occurrence. Obesity and heavy alcohol use may also contribute to pancreatic problems that lead to cyst formation.

Doctors usually discover IPMNs through imaging tests like CT scans or MRI. These scans show cysts in the pancreas and can reveal concerning features like mural nodules, or bumps inside the cyst walls. An MRI with a special pancreas protocol, called MRCP, gives the clearest view of the pancreatic ducts. Endoscopic ultrasound uses a tiny camera on a flexible tube to get close-up images and can take tissue samples if needed.

Blood tests help identify complications from IPMN, especially inflammation of the pancreas. Rite Aid offers lipase testing as an add-on to our health panel. Lipase is an enzyme that rises in the blood when the pancreas becomes inflamed. Elevated lipase can indicate that an IPMN is blocking the pancreatic duct and causing recurrent pancreatitis. Regular monitoring with imaging and blood work helps doctors track changes and catch any progression toward cancer early.

• Regular surveillance with MRI or CT scans every 6 to 12 months for low-risk cysts
• Surgical removal for IPMNs with high-risk features like large size or solid nodules
• Endoscopic ultrasound monitoring to check for worrisome changes
• Smoking cessation to reduce cancer progression risk
• Maintaining healthy weight through balanced nutrition
• Limiting alcohol to reduce pancreatic inflammation
• Low-fat diet to ease digestive symptoms
• Pancreatic enzyme supplements if digestion is affected
• Pain management during acute pancreatitis episodes
• Blood sugar monitoring, as new diabetes can be a warning sign